Page 4 - Optune Gio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NovoCure (NASDAQ:NVCR – Get Free Report) and Minerva Surgical (NASDAQ:UTRS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Institutional and Insider Ownership 84.6% of NovoCure shares […]

Wedbush reissued their neutral rating on shares of NovoCure (NASDAQ:NVCR – Free Report) in a report published on Wednesday, RTT News reports. The firm currently has a $21.00 price target on the medical equipment provider’s stock. Wedbush also issued estimates for NovoCure’s Q4 2025 earnings at ($0.36) EPS, FY2026 earnings at ($1.45) EPS and FY2027 […]

NovoCure Limited (NASDAQ:NVCR) Q4 2023 Earnings Call Transcript February 22, 2024 NovoCure Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. Welcome to the NovoCure Q4 2023 Earnings Conference Call. At this […]

Operator: Good day and thank you for standing by. Welcome to the NovoCure Q4 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.